Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes

PNEUMOVAX™ 23, a 23-valent polysaccharide pneumococcal vaccine (PPV23), covers 65% to 91% of the isolates recovered from adult cases of invasive pneumococcal disease. Several studies have demonstrated that pneumococcal serotypes 31, 11A, 35F, 17F, 3, 16F, 19F, 15B, and 10A are associated with higher...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Ciprero, Karen L., Marchese, Rocio D., Richard, Patrick, Baudin, Martine, Sterling, Tina M., Manoff, Susan B., Radley, David, Stek, Jon E., Soubeyrand, Benoît, Grabenstein, John D., Samson, Sandrine I., Musey, Luwy K.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994760/
https://ncbi.nlm.nih.gov/pubmed/27002793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1156270
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados